With support from both the St. Baldrick’s Foundation and the American Cancer Society, analysis of data from over 5,000 kids with cancer may provide new opportunities for diagnosis, prognosis, and treatment of pediatric acute myeloid leukemia (AML).
For more than 40 years the main treatment for pediatric osteosarcoma has not changed. Patients with this type of aggressive bone cancer, most often diagnosed in teens, are in desperate need of new options. Fewer than 30% of patients survive when osteosarcoma has spread beyond the primary tumor at diagnosis.
To make a significant impact for kids fighting osteosarcoma, five funding partners have banded together with St. Baldrick’s to support a new grant – The Fight Osteosarcoma Together (FOT) Super Grant. Today we are excited to announce that the recipient of this three-year, $1.5 million grant is Dr. Patrick Grohar, at the Children’s Hospital of Philadelphia. The goal: a clinical trial to test a new treatment within three years.
Patrick J. Grohar, M.D., Ph.D.
I will never forget the evening of Sunday, December 14, 2014, when the ER doctor and the pediatric neurologist on call entered our triage room and told us that our sweet eight-year-old girl had a huge brain tumor and life-threatening obstructive hydrocephalus. That moment left an indelible mark on my heart. The fear, the heartache, helplessness, and especially the unyielding desire to eliminate our baby’s pain and suffering were soul-crushing.
“Supergirl Julia” today
Each survivor’s risk of late effects of cancer treatment depends on their tumor, specific treatments, age, genetic makeup and other factors. Surgeries, chemotherapies, radiation, stem cell transplants and other treatments take a toll on the body – and sometimes the mind – in many ways. Some late effects make life more difficult; others are life-threatening.
Heart and lung problems are common, as are secondary cancers.
Other late effects can include hearing problems, hormonal imbalances, difficulty growing, mental health needs or cognitive deficiencies, bone density issues and easy bone fractures, fertility and reproductive problems, and more.
The next generation of childhood cancer researchers is rolling up their lab coat sleeves and doubling down on the fight to end childhood cancers.
Thanks to donors like you, these doctors will train with leaders in the field and launch new research projects to answer pressing questions in the quest to conquer childhood cancers.
Explore the new research you’re supporting:
This new investment of $3.5 million brings the total granted by St. Baldrick’s for research since 2005 to more than $310 million.
The 9 grants include new funding for 3 new St. Baldrick’s Scholars, and 1 new International Scholar from Uganda. Also receiving new funding for projects already underway are 4 team science projects (Consortium grants) and 1 Strategic Initiative: the Pediatric Cancer Data Commons.Honored Kid Augie
Combined Efforts: First Partnership Grants of the St. Baldrick’s Foundation and the American Cancer Society
When a patient is fighting cancer, a combination of two cancer treatments often works better than just one. Since August of 2019, another kind of combination has been at work to fight childhood cancers: A partnership between the St. Baldrick’s Foundation and the American Cancer Society.
Today we are excited to announce the first set of research projects to be supported by this partnership, totaling more than $2.8 million.
The next generation of childhood cancer researchers are hard at work to create better futures for kids with cancer. Thanks to your fundraising and generosity there is hope, and the future is bright!
You – St. Baldrick’s donors and fundraising participants – make this possible. Thank you!
St. Baldrick’s Foundation Fellowship Awards support new pediatric oncology doctors for two to three years to conduct childhood cancer research while receiving advanced training under a mentor.
Take a look at the three stellar new 2021 Fellows whose research you’re supporting:
Older Posts »